Overview
Strattera is the brand name for atomoxetine, a non-stimulant drug used to treat ADHD (Attention Deficit Hyperactivity Disorder). It is a selective norepinephrine reuptake inhibitor and works differently from stimulants, such as Ritalin, which are used to treat ADHD. It is thought that Strattera works by blocking the reuptake of norepinephrine, which increases norepinephrine levels. Norepinephrine may help regulate impulse control, organization, and attention span. Strattera was FDA approved in November 2002 and is the only FDA approved ADHD medication for adults.

Why is this drug prescribed?
Strattera is used to treat Attention Deficit Hyperactivity Disorder (ADHD or ADD) in children, adolescents, and adults. It is sometimes chosen because the stimulant properties of other ADHD medications tried have caused undesirable side effects such as insomnia or tics, which Strattera is not supposed to do.

Warnings and Precautions
Strattera has not been studied in children under 6 years old.

While Strattera, as a non-stimulant ADHD treatment, is expected to cause fewer problems related to weight-loss or failure to gain sufficient weight, weight loss is still a possible side effect and the weight of children taking Strattera should be carefully monitored.

For Pregnant or Nursing Mothers: Strattera is not well studied in pregnancy or lactation and is not recommended during pregnancy or for mothers who are breast-feeding.

Contraindications
Strattera should Not be used for people with the following medical conditions:

1. An allergy or hypersensitivity to Strattera (atomoxetine).
2. Narrow angle glaucoma